Latest News

All the news from Anaphylaxis UK

Looking for Allergy Alerts?

Allergy Alerts

Latest News from Anaphylaxis UK

Immunotherapy treatment for house dust mite allergy now available through NHS Scotland  13th August 2026

An immunotherapy treatment for house dust mite allergy has been made available through the NHS in Scotland.  The Scottish Medicines Consortium (SMC) has accepted Acarizax (12 SQ-HDM sublingual immunotherapy) for adults aged 18–65 with moderate to severe, persistent house dust mite allergic rhinitis.
[…]

Read more
Climbing for Greg: Brother takes on Mount Kilimanjaro in memory of sibling lost to anaphylaxis 10th August 2026

When Josh begins his ascent of Mount Kilimanjaro later this year in aid of Anaphylaxis UK, every step he takes up Africa’s highest peak will be in memory of his brother Greg, who tragically died in December 2024 after an
[…]

Read more
Fundraiser Andrew sets sights on remote Hengduan summit to support Anaphylaxis UK and Cancer Research UK 4th August 2026

19-year-old Andrew is preparing to take on one of China’s most remote peaks in an extraordinary expedition that could make him the first recorded British climber to reach its summit, all while raising funds and awareness for two causes close
[…]

Read more

News Type:

Department of Education publishes new statutory guidance on allergies in schools 6th July 2026

Following the Government’s announcement earlier this year of new allergy guidance to help keep children safe in schools, the Department for Education has now published its statutory guidance. The new requirements will become mandatory from 1 September 2026. From the

Read more
Lower dose EURneffy® nasal adrenaline spray approved by MHRA for younger children 30th June 2026

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a lower-dose version of the adrenaline nasal spray, EURneffy®, for the emergency treatment of serious allergic reactions (anaphylaxis) in children aged four years and over. This adrenaline device option is

Read more
Anaphylaxis UK welcomes launch of Natasha’s Prize 22nd June 2026

The announcement that Natasha’s Foundation has launched Natasha’s Prize – a groundbreaking £10 million fund dedicated to research into preventing allergies – has been hugely encouraging for the allergy community.  As a charity supporting people living with serious allergies, Anaphylaxis UK warmly

Read more
NICE publishes updated anaphylaxis guidelines on assessment and referral after emergency treatment 18th June 2026

The National Institute for Health and Care Excellence (NICE) has published updated guidance on the assessment and referral of people following emergency treatment for anaphylaxis. This new guideline replaces NICE guideline CG134 (December 2011).  The update aims to improve the

Read more
Beyond the Lens: How Ultra‑HD Streaming Is Redefining the Live‑Dealer Experience 17th June 2026

The past decade has turned high‑definition video from a luxury into a daily expectation. From 4K televisions in living rooms to 1080p streams on smartphones, users now assume crystal‑clear visuals no matter the content. That assumption has seeped into online

Read more
Statement regarding merge of Anaphylaxis UK and Allergy UK 11th June 2026

Anaphylaxis UK and Allergy UK to merge, creating a stronger, unified voice for people living with allergy and anaphylaxis.  Anaphylaxis UK and Allergy UK today announce their intention to merge on the 1st of October, bringing together their expertise to create a more powerful, unified voice

Read more
New review highlights ethnic inequalities in children’s food allergy care 21st May 2026

A new international review has highlighted important inequalities in the prevalence, management, and outcomes of IgE-mediated food allergies among children from different ethnic backgrounds. The scoping review, published in the World Allergy Organization Journal, analysed 37 studies from high-income countries

Read more
Critical delays in use of AAIs in children, call to action  18th May 2026

New research from the University of Bristol and Bristol Royal Hospital for Children has highlighted critical delays in the use of adrenaline auto-injectors (AAIs) in children experiencing fatal food-induced anaphylaxis, prompting calls for urgent improvements in awareness, preparedness and guidance.   The findings, presented on

Read more
Visit our stand at the Allergy & Free From Show 1st May 2026

If you’re at the Allergy & Free From Show on 9-10 May at NEC Birmingham, come and say hello to our team of staff and volunteers with lived experience of allergies on stand H16. The team will be ready to

Read more